Jinxin Fertility Group Limited (abbreviation: JXR) disclosed a new round of on-market share repurchases on 13 May 2026.

Key points

• Latest transaction: 3.27 million ordinary shares were bought back on the Hong Kong Stock Exchange at prices between HKD 2.38 and HKD 2.43, for a total consideration of HKD 7.81 million. All shares are designated for cancellation.

• Outstanding shares: Issued share capital stood unchanged at 2.71 billion shares as of 13 May 2026, as the repurchased shares await formal cancellation.

• Pending cancellation pool: Including the 13 May purchase, JXR has 26.21 million shares bought back but not yet cancelled since 27 March 2026, equivalent to approximately 0.97% of current issued shares.

• Mandate utilisation: Since the AGM approval on 26 June 2025, the company has repurchased 65.87 million shares—about 2.40% of the shares outstanding on the mandate date—under its authorised limit of 274.47 million shares.

• Moratorium: In accordance with Hong Kong listing rules, JXR is restricted from issuing new shares or transferring treasury shares until 12 June 2026, 30 days after the most recent buyback.

These transactions are confirmed to comply with the Hong Kong Stock Exchange’s Main Board Rules, and no material changes have been made to the company’s previously filed explanatory statement dated 4 June 2025.